Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes Related to Use of Soberlink Within In-Home Addiction Treatment Program for Individuals With Alcohol Use Disorder

NCT03902171 is registered in ClinicalTrials.gov with In-Home Addiction Treatment Institute, Inc. as lead sponsor.

NCT NCT03902171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03902171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes Related to Use of Soberlink Within In-Home Addiction Treatment Program for Individuals With Alcohol Use Disorder
Lead sponsor
In-Home Addiction Treatment Institute, Inc.
Phase
Observational
Overall status
Unknown status
Start date
April 2, 2019
Completion date
September 5, 2020
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder